[Today's focus]
COSCO HYUNENG (01138.HK) Yingxi: Expected medium-term net profit of about 2.65 billion yuan, up about 1397.2% year on year
COSCO HYUNENG (01138.HK) announced that the company expects to record net profit attributable to company owners of about RMB 2.65 billion in the six months ending June 30, 2023, an increase of about RMB 2,473 billion or an increase of about RMB 1,397.2% over the net profit attributable to company owners of about RMB 177 million after the same period in 2022.The main reasons for the increase in net profit attributable to company owners in the first half of 2023 compared to the same period last year are as follows: In the first half of 2023, freight rate levels in the international oil transport market showed strong performance amid sharp fluctuations. According to Baltic Sea Exchange data, from January to June 2023, the average daily earnings (TCE) for the Middle East-China (TD3C) of the Global VLCC (VLCC) was 43,147 US dollars/day, an increase of about 562% over the same period last year. The rise in demand for Chinese oil and the contribution of crude oil exports from the US, the Gulf and Brazil to long-range shipping routes are the main driving factors for the rise in VLCC freight rates in the first half of 2023. The Group scientifically researches market trends, flexibly lays out global shipping positions, captures transaction opportunities in regional markets in a timely manner, and increases overall fleet revenue.
Geely Automobile (00175.HK): Total sales volume of 137,900 cars in June increased 9% year-on-year
Geely Automobile (00175.HK) announced that the Group's total sales volume in June 2023 was 137,897 vehicles, an increase of about 9% over the same period last year.In June 2023, Proton achieved sales of 14,499 cars, roughly the same level as the same period last year. Furthermore, Proton achieved cumulative sales of 80,506 cars in the first half of 2023, an increase of about 34% over the same period last year.
Gacos-B (01167.HK): Beijing Gacos plans to receive a capital increase of 150 million yuan from Yizhuang State Investment to be used for R&D, production and commercialization of KRASG12C inhibitors and other innovative projects
Gacos-B (01167.HK) announced that Gacos (Hong Kong) Pharmaceutical Co., Ltd. (“Garcos (Hong Kong)”), an indirect wholly-owned subsidiary of the company, Beijing Gacos New Drug Research and Development Co., Ltd. (“Beijing Gacos”), and Wang Yinxiang, executive director, CEO and chairman of the board of directors of the company, recently signed a capital increase agreement with Beijing Yizhuang International Investment and Development Co., Ltd. (“Yizhuang)”.According to the capital increase agreement, Yizhuang State Investment proposed to invest RMB 150 million in cash to subscribe for additional registered capital from Beijing Garcos. After the capital increase is completed, Beijing Gacos will be owned by Gacos (Hong Kong) about 96.97% and Yizhuang SDIC will own about 3.03%.
Poly Real Estate Group (00119.HK): Contract sales of 37.4 billion yuan in the first half of the year increased 127% year-on-year
Poly Real Estate Group (00119.HK) announced that in June 2023, the Real Estate Group achieved a contract sales amount of about RMB 4.1 billion, a contract sales area of about 164,000 square meters, and an average contract sales price of about RMB 24,902 per square meter.As of June 2023, the Real Estate Group achieved a cumulative contract sales amount of about RMB 37.4 billion, an increase of 127% over the previous year. The cumulative contract sales area is about 1,482 million square meters, and the average contract sales price is about RMB 25,231 per square meter.
Hima Ophthalmology (03309.HK) plans to establish a joint venture to develop innovative drugs in the field of ophthalmology and oncology
Hima Ophthalmology (03309.HK) announced that the board of directors is pleased to announce that Lin Shunchao and Hima Medical Group signed a joint venture agreement on July 6, 2023 to jointly invest in and develop innovative pharmaceutical projects in ophthalmology and oncology.According to the joint venture agreement, when the joint venture business process requires capital, within 10 business days after the joint venture issues reasonable notice to the joint venture, Lin Shunchao and Hima Medical Group will inject up to 4.67 million US dollars and 2 million US dollars in cash according to their respective share ratios in the joint venture company (that is, 70% and 30% of the registered share capital of the joint venture, respectively) to support the joint venture in promoting the achievement of its business goals.The name of the joint venture is Xihua Pharmaceutical Co., Ltd. The joint venture was and will continue to be 70% owned by Dr. Lin Shunchao and 30% by Hima Healthcare Group, respectively, as of the announcement date. The cooperation will commence on the date of the joint venture agreement until it ends in the manner specified in the joint venture agreement.
[Financial Data]
Sharing Group (03344.HK) turned a loss into a profit of HK$21.808 million in the mid-term of FY2023
[Operational data]
Xuhui Holding Group (00884.HK)'s cumulative contract sales in the first half of the year were about 41.94 billion yuan
Zhongjun Group Holdings (01966.HK) achieved cumulative contract sales of approximately RMB 20.084 billion in the first half of the year
The total contract sales of Hesheng Innovation Group (00754.HK) in the first half of the year was about 16.062 billion yuan
China Overseas Development (00688HK) contract property sales amount in June was about 33.199 billion yuan
China Overseas Hongyang Group (00081.HK): Cumulative contract sales of 25.94 billion yuan in the first half of the year increased 24.6% year on year
Lemmon International (03688.HK) pre-sale volume for the first half of the year was approximately HK$422 million
CGN (01816.HK): Total feed-in electricity volume in the first half of the year was 105.918 billion kilowatt-hours, up 14.09% year-on-year
Jianye Real Estate (00832.HK) had total property contract sales of 10.025 billion yuan in the first half of the year
[Mergers, acquisitions, and sales]
Shengneng Group (02459.HK) plans to acquire assets used to produce graphite electrodes for 80.5 million yuan
Ruiwei Asset Management (01835.HK) plans to acquire two stores in Wuhou District of Chengdu for 46.5 million yuan
Huahe Holdings (09938.HK) plans to acquire properties in Hong Kong's New Territories for HK$8.45 million
[Investment and operation]
Baiyunshan (00874.HK)'s wholly-owned subsidiary received a notice of approval for clinical trials of granular drugs to nourish the liver
Luye Pharmaceutical (02186.HK): Class 1 new drug LY03014 completed the phase II clinical trial in China, and all subjects were enrolled
Litmi from Hainan (01936.HK) signed a cooperation agreement with Xi'an Zhouchen to invest in Wharf Village, Dongjiao Town, Wenchang City
Changshi Group (01113.HK): Revocation of the listing and trading status of CIVITAS SOCIAL HOUSING PLC shares on the London Stock Exchange
Beikong Urban Resources (03718.HK) won the bid for the Heyuan Sanitation and Cleaning Franchise Project with an estimated total contract value of 237 million yuan
Shanghai Pharmaceutical (02607.HK): Capecitabine tablets receive drug registration certificate
Fosun Pharmaceuticals (02196.HK) Holding Subsidiary Receives Drug Registration Application Accepted
[Fund Financial Management]
Fudan Zhang Jiang (01349.HK) subscribes to 200 million yuan of China Merchants Bank structured deposit products
[Cancellation of repurchase]
Tencent Holdings (00700.HK) spent HK$402 million to buy back 1.22 million shares on July 6
AIA (01299.HK) spent HK$132 million on July 6 to buy back 1.682 million shares
Mengniu Dairy (02319.HK) spent HK$10.347,300 to buy back 350,000 shares on July 6
HSBC Holdings (00005.HK) spent HK$145 million to buy back 2.35 million shares on July 5
Bank of East Asia (00023.HK) spent HK$3,037,900 to buy back 286,600 shares on July 6
Seashell-W (02423.HK) spent US$2.193,600 on July 5 to buy back 450,000 shares
Yum China (09987.HK) spent US$1 million to buy back 17,800 shares on July 5
Jinke Services (09666.HK) spent HK$2.24 million to buy back 200,000 shares on July 6
Bubble Mart (09992.HK) spent HK$3.184 million to buy 180,000 shares on July 6
Fosun International (00656.HK) spent HK$2.156,000 to buy back 400,000 shares on July 6
Huiliang Technology (01860.HK) spent HK$5.502 million to buy back 1.625 million shares on July 6
ESR (01821.HK) purchased 462,800 shares at a cost of HK$6.0671,000 on July 6
Standard Chartered Group (02888.HK) spent £14.8814 million on July 5 to buy back 2.165,600 shares
Haier Smart Home (06690.HK) spent 12.5049 million yuan on July 6 to buy back 550,000 A-shares
[Equity Incentives]
BeiGe Shenzhou (06160.HK) granted 2,329 share buybacks and 60,200 restricted share units
Xindong Company (02400.HK) has granted a total of 852,700 shares
North Asia Strategy (08080.HK): Granted a total of 9.86 million shares
Casa Tianjiao (02223.HK) grants 6.2 million shares